Ajanta Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 ,inter alia, to consider and approve Unaudited consolidated and standalone financial results of the Company for the second quarter and half year ended 30th September 2026

Ajanta Pharma Limited Ajanta Tower, 54-A, M Vasanji T +91 22 6060 9000 Road, Chakala, Andheri (E), E legal.info@ajantapharma.com Mumbai 400 093, India W www.ajantapharma.com 15th October 2026 BSE LIMITED National Stock Exchange of India, Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor, Plot no. Dalal Street, C/1, G Block, Bandra Kurla Complex, Mumbai – 400001 Bandra (East), Mumbai – 400 051 Scrip Code: BSE – AJANTPHARM 532331 Scrip Code: NSE AJANTPHARM EQ Sub.: Notice of Board Meeting Dear Sirs/Madam, Pursuant to Regulation 29 of the Listing Regulations, we hereby inform that a Meeting of the Board of Directors of the Company will be held on Friday, 30th October 2026, to inter-alia, consider and approve unaudited consolidated and standalone financial results of the Company for the second quarter and half year ended 30th September 2026. Kindly take the above information on record. Thanking you, Yours faithfully, Gaurang Shah Sr. VP – Legal & Company Secretary Corporate Identity Number - L24230MH1979PLC022059